Hospital Sales

Discussion in 'Ortho-McNeil' started by Anonymous, Jan 31, 2011 at 11:32 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I just applied for a hospital sales position within your company. Serious answer's please. What are the present products that they sell, and will the new anti-coagulant be part of the hospital pipeline?
     

  2. Anonymous

    Anonymous Guest

    Of course 'it' will be part of the hosp pipeline.
     
  3. Anonymous

    Anonymous Guest

    Again the question was asked what are the product's the hospital team have in the bag? Anti-coagulation many times starts at one of the many coumadin clinics that the card offices run. Yes it does start in thehospital for afib, stroke prevention. However, it can also be viewed as an office specialty drug. I think that is why the question was asked!
     
  4. Anonymous

    Anonymous Guest

    If xarelto and pradaxa are as good as advertised coumadin clinics will become obsolete. No anticoagulation to manage.
     
  5. Anonymous

    Anonymous Guest

    When is word expected from the fda on xarelto anyway?
     
  6. Anonymous

    Anonymous Guest

    Can anyone give me the name and number of the recruiter(s) who are screening for these CV positions? thanks
     
  7. Anonymous

    Anonymous Guest

    Are you joking? All of cafepharma would be calling in.
     
  8. Anonymous

    Anonymous Guest

    OP: if you get an interview, you can ask about what drugs are in the bag. It has changed quite a few times in recent quarters and will change again once riva is approved. Regarding recruiters: J&J uses mostly internal recruiters. They will call you if your resume looks good next to the other 1000 they receive.
     
  9. Anonymous

    Anonymous Guest

    Interviews are begining to take place across the country.
     
  10. Anonymous

    Anonymous Guest

    Got a call this week. Interviewing in 2 weeks.
     
  11. Anonymous

    Anonymous Guest

    Yes, Riva will be added upon launch. Until then they will have Grunenthal/Johnson & Johnson's novel opioid analgesic, Remicade, LEVAQUIN (as a contest until it goes generic)
    maybe something else... can't recall. For sure those mentioned above.

     
  12. Anonymous

    Anonymous Guest

    What is the e-mail format for the company?
     
  13. Anonymous

    Anonymous Guest

    what part of the country are you in?
     
  14. Anonymous

    Anonymous Guest

    Good place to be. The other product is Doribax, a carbapenem antibiotic.
     
  15. Anonymous

    Anonymous Guest

  16. Anonymous

    Anonymous Guest


    jdoe@its.jnj.com
     
  17. Anonymous

    Anonymous Guest

    Good place to be if you don't mind limited, or in most cases, no access in hospitals, and you have been resigned to become just another specialty rep. calling on doctors offices in private practice and trying to see them with no drugs to sample. You need to have thick skin to be in hospital these days, and realize that you have become a lunch a day rep. like Oncology. It can be brutal trying to see some of the docs you need to on more than a 1X or every other month basis. The NDM strain of ESBL's are 40% resistnat to carbs., and once KPC's start kicking in full force, then you will have no antibiotic to sell. Don't forget about fair balance, and remind the docs that overuse of carbs causes multi-drug resistant pseudomonas, which is becoming so severe (just published study in the Lancet) and that it has impacted all anti-psuedomonals thanks to the carbs. Then while your add it remind them that overuse of floruoquinolones is the most highly linked antimicrobial contributer to MRSA infections @ 34%.
     
  18. Anonymous

    Anonymous Guest

    Hospital sales used to be a premier field-based sales position. Lack of access has made it an exercise in futility and frustration. Forget about any type of access due to inservices once the Sunshine Act goes into effect. Long-standing relationships don't make a difference anymore as drug usage and utilization is based solely on managed care, reimbursement, and what administration dictates to hospital employees to increase revenue. Experienced doctors and nurse practitioners are losing their jobs to less expensive doctors and nurses fresh out of school, physicians assistants, nurses, medical assistants, and technicians. Doctors are not willing to lose their job security to fight over usage for one drug over another and are forced to follow administrative policies for drug utilization and cost savings. Most hospitals are in the red and in danger of going bankrupt and shutting down. It doesn't even make a difference if you have thick skin or not. Selling in the hospital setting is becoming next to impossible.
     
  19. Anonymous

    Anonymous Guest

  20. Anonymous

    Anonymous Guest

    Sounds believable. Fact is territories now should include offices, clinics and hospitals and let the rep prioritize by opportunity. The geography would be smaller and the rep would "own" all of the business in their geography but they would need to posess the business acumen to do so as well as adjust their approach based on the customer type (aka those who are business savvy and can think on their feet). There is not a hospital specialty need anymore unless your product is infused or only dispensed on an inpatient basis.

    But then again, if you believe some of the other threads from these ridiculous people, all reps will be replaced with contract people or maybe even with those who have a "strong scientific background" because thats what Dr's want - wink - wink.